Diversify Advisory Services LLC Sells 3,249 Shares of UnitedHealth Group Incorporated $UNH

Diversify Advisory Services LLC trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.7% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 30,147 shares of the healthcare conglomerate's stock after selling 3,249 shares during the period. Diversify Advisory Services LLC's holdings in UnitedHealth Group were worth $12,260,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Corient Private Wealth LP bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $245,516,000. Legal & General Group Plc purchased a new position in shares of UnitedHealth Group during the second quarter valued at about $2,444,928,000. Jupiter Topco LLC bought a new stake in shares of UnitedHealth Group in the second quarter worth about $2,019,844,000. BlackRock Inc. increased its holdings in shares of UnitedHealth Group by 4.6% in the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock worth $31,946,594,000 after purchasing an additional 3,395,530 shares during the last quarter. Finally, Canada Pension Plan Investment Board purchased a new stake in shares of UnitedHealth Group in the second quarter worth about $971,757,000. 87.86% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the business's stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.19% of the stock is owned by company insiders.

UnitedHealth Group Price Performance

NYSE:UNH opened at $419.70 on Wednesday. The firm has a market capitalization of $376.72 billion, a price-to-earnings ratio of 23.97, a PEG ratio of 1.47 and a beta of 0.60. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78. The business has a 50 day simple moving average of $387.40 and a 200-day simple moving average of $387.49. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm had revenue of $112.70 billion for the quarter, compared to the consensus estimate of $111.31 billion. During the same quarter in the previous year, the company posted $2.59 EPS. The company's revenue for the quarter was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 20.64 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group's payout ratio is presently 53.00%.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: A Seeking Alpha analyst initiated coverage with a Strong Buy rating and a $533 price target, citing margin recovery, improved Optum Health contracts and AI-related efficiencies as potential drivers of double-digit EPS growth through 2028. The analyst also viewed UNH’s valuation as discounted relative to the healthcare sector. UnitedHealth: Optum's Recovery Supports My Strong Buy Rating
• Positive Sentiment: UnitedHealth was selected as a CNBC “Final Trades” stock after its better-than-expected quarterly results, adding to favorable short-term investor sentiment. Twilio, Transocean and a Health Care Stock on CNBC's Final Trades
• Positive Sentiment: Analysts and investors are reassessing UNH after the earnings beat and raised outlook, while commentary suggests the stock’s recent momentum reflects renewed confidence in medical-cost trends and operational execution. UnitedHealth Group Has The Market Asking A Bigger Question
• Neutral Sentiment: UnitedHealth’s results have renewed interest in healthcare ETFs with UNH exposure, although diversification may reduce the impact of company-specific gains and limit direct upside. Healthcare ETFs to Buy as UnitedHealth Beats on Q3 Earnings
• Negative Sentiment: A competing analyst downgraded UNH from Strong Buy to Buy, arguing that the shares may already reflect much of the recovery at roughly 20 times forward earnings. Valuation, medical-cost pressure and execution risks remain concerns. UnitedHealth: My Thesis Has Played Out, I Wouldn't Chase Here
• Negative Sentiment: Reports of rising healthcare costs, reduced services and higher prescription-drug prices for older Americans could increase political scrutiny and pressure insurers’ affordability and retention metrics. Older Americans Brace for Higher Healthcare Costs Ahead of Midterms
• Negative Sentiment: Declining individual-market enrollment and reports that millions of seniors may lose Medicare Advantage plans highlight regulatory, membership and pricing risks for the broader insurance industry, including UNH. 3.2 Million Seniors Will Lose Their Medicare Advantage Plans in 2027

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Wells Fargo & Company increased their price target on UnitedHealth Group from $397.00 to $485.00 and gave the company an "overweight" rating in a research note on Monday, July 13th. Deutsche Bank Aktiengesellschaft lifted their price objective on UnitedHealth Group from $370.00 to $467.00 and gave the stock a "hold" rating in a research note on Friday, July 17th. TD Cowen reaffirmed a "hold" rating and set a $402.00 price objective on shares of UnitedHealth Group in a report on Thursday, October 15th. Evercore increased their target price on UnitedHealth Group from $400.00 to $480.00 and gave the company an "outperform" rating in a research report on Tuesday, July 7th. Finally, Barclays cut their target price on shares of UnitedHealth Group from $441.00 to $440.00 and set an "overweight" rating for the company in a report on Wednesday, October 14th. Twenty equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $463.57.

UnitedHealth Group Profile

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.